I have learned not to predict time lines or outcomes relative to government agencies but what you outlined is certainly possible. Think possible approval time would be June to September next year. But as you point out there are quite a few surgeons already using Recell for traumatic wounds. Still think it's a possibility this could be handled with a label expansion before next June. Only a possibility, not a prediction.
- Forums
- ASX - By Stock
- AVH
- Webinar
Webinar, page-67
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.63 |
Change
0.160(6.48%) |
Mkt cap ! $179.0M |
Open | High | Low | Value | Volume |
$2.54 | $2.64 | $2.54 | $874.2K | 336.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3056 | $2.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.63 | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2671 | 2.620 |
2 | 23181 | 2.580 |
2 | 10350 | 2.560 |
2 | 4338 | 2.550 |
1 | 1200 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.630 | 4999 | 1 |
2.650 | 1070 | 2 |
2.700 | 1110 | 2 |
2.730 | 5000 | 1 |
2.740 | 4614 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |